疑似心脏结节病室性心律失常结局的预测:心血管磁共振表型分型与学会植入式心律转复除颤器置入建议的比较
这项多中心研究纳入1514例组织学确诊结节病且因疑似心脏受累行心血管磁共振检查、不符合二级预防ICD适应证的患者,比较心血管磁共振表型分型与学会建议对致命性或危及生命室性心律失常复合结局的预测准确性。中位随访4.5年(最长10年)期间84例发生结局,心血管磁共振表型分型判别准确性优于学会建议,5年和10年AUC分别为0.861和0.776。
要点
- 高危心血管磁共振表型5年和10年结局发生率分别为24.0%和35.0%,高于符合学会建议者。
- 低危表型患者5年和10年结局发生率分别为0.7%和2.6%。
- 心血管磁共振表型分型预测5年和10年结局的AUC分别为0.861和0.776,优于学会建议。
核心结论
- 在疑似心脏结节病患者中,心血管磁共振表型分型对致命性或危及生命室性心律失常的判别准确性高于学会建议,提示其可能更有效地识别一级预防ICD的候选者。
研究设计与样本
- 多中心研究,纳入1514例组织学支持的结节病患者,均因疑似心脏受累行心血管磁共振检查且不符合二级预防ICD适应证。
关键影像表现/征象
- 高危心血管磁共振表型与更高的5年和10年结局发生率相关(分别为24.0%和35.0%),高于符合学会建议者。
- 低危表型患者5年和10年结局发生率分别为0.7%和2.6%。
诊断标准与关键数值
- 心血管磁共振表型分型预测5年结局的AUC为0.861,预测10年结局的AUC为0.776。
- 心血管磁共振表型分型对研究结局的校正亚分布风险比为19.8。
临床应用与阅片要点
- 原文结论提示心血管磁共振表型分型可能更有效地识别一级预防ICD候选者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND AIMS: Implementing societal recommendations for primary prevention implantable cardioverter-defibrillators (ICDs) in cardiac sarcoidosis requires an accurate diagnosis. However, cardiac sarcoidosis diagnostic schemes are inconsistent and often produce conflicting results. This study aimed to compare the discriminative accuracy of cardiovascular magnetic resonance imaging (CMR) phenotyping with the societal recommendations for predicting long-term ventricular arrhythmic outcomes in patients with suspected cardiac sarcoidosis, regardless of their diagnostic status.
METHODS: This multicentre study included patients with histology-supported sarcoidosis who underwent CMR for suspected cardiac involvement and were ineligible for secondary prevention ICDs. The study outcome was a composite of fatal or life-threatening ventricular arrhythmias. Outcomes were compared based on eligibility for ICDs by societal recommendations and CMR phenotyping.
RESULTS: Among 1514 patients, 84 experienced the study outcome during a median follow-up of 4.5 years and a maximum follow-up of 10 years. The high-risk CMR phenotype was associated with higher 5- and 10-year incidences of the outcome (24.0% and 35.0%, respectively) compared with those who met societal recommendations. Patients with low-risk phenotypes had lower incidences (0.7% and 2.6%). Cardiovascular magnetic resonance imaging phenotyping outperformed societal recommendations in discriminative accuracy, with areas under the curve of 0.861 and 0.776 for 5- and 10-year outcomes, respectively. Additionally, CMR phenotyping had the highest adjusted subdistribution hazard ratio (19.8) for the study outcome.
CONCLUSIONS: In patients with suspected cardiac sarcoidosis, CMR phenotyping showed greater discriminative accuracy than societal recommendations for predicting fatal or life-threatening ventricular arrhythmias, suggesting that it may be more effective at identifying candidates for primary prevention ICDs.
引用
- Mathijssen H, Bawaskar PH, Rochlani Y, et al. Prediction of ventricular arrhythmic outcomes in suspected cardiac sarcoidosis: a comparison of cardiovascular magnetic resonance phenotyping vs. societal recommendations for implantable cardioverter-defibrillator placement. Eur Heart J. 2025. PMID: 40400457. doi:10.1093/eurheartj/ehaf338
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。